4 results
The objective of the study is to confirm that PCNSL is positive on 89Zr-rituximab PET imaging.
The primary objective of this randomized controlled trial is to investigate the efficacy of dashboard driven dosing of infliximab compared to standard dosing during the induction phase in patients with acute severe ulcerative colitis, as evaluated…
To explore skin adaptation after repeated sub-erythemal UV-dose and individual factors that might underlie this process.
Primary Objectives* To evaluate the efficacy of golimumab in inducing clinical remission as assessed by the Mayo score,in pediatric participants with moderately to severely active ulcerative colitis (UC).* To evaluate the safety profile of golimumab…